Allianz SE cut its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.7% during the second quarter, according to the company in its most recent 13F…
Read more Allianz SE Decreases Stake in Johnson & Johnson $JNJHBK Sorce Advisory LLC cut its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.5% in the second quarter, HoldingsChannel reports. The firm owned…
Read more Johnson & Johnson (NYSE:JNJ) Shares Sold by HBK Sorce Advisory LLCTweedy Browne Co LLC cut its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.1% during the first quarter, according to its most recent 13F filing…
Read more Johnson & Johnson (NYSE:JNJ) is Tweedy Browne Co LLC’s 3rd Largest PositionBurke & Herbert Bank & Trust Co. reduced its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 18.4% in the 3rd quarter, HoldingsChannel reports.…
Read more Johnson & Johnson (NYSE:JNJ) Shares Sold by Burke & Herbert Bank & Trust Co.Kingdom Financial Group LLC. lifted its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 258.0% during the third quarter, Holdings Channel reports. The fund…
Read more Johnson & Johnson (NYSE:JNJ) Shares Acquired by Kingdom Financial Group LLC.M&R Capital Management Inc. reduced its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.2% in the 3rd quarter, according to the company in its most…
Read more Johnson & Johnson (NYSE:JNJ) Shares Sold by M&R Capital Management Inc.Vision Capital Management Inc. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% in the 2nd quarter, according to the company in its most…
Read more Vision Capital Management Inc. Has $8.67 Million Stake in Johnson & Johnson (NYSE:JNJ)Johnson & Johnson Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It…
Read more JNJ Stock Price | Johnson & Johnson Stock Quote (U.S.: NYSE) | MarketWatchMonument Capital Management acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with…
Read more Monument Capital Management Acquires New Position in Johnson & Johnson (NYSE:JNJ)This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/johnson-and-johnson-stock-dividend-aristocrats-aa46e2db Sept. 1, 2023 7:33…
Read more J&J Dividend Decision Shows Power of Free Cash FlowJohnson & Johnson on Wednesday issued new financial guidance after spinning out the consumer-health company Kenvue While its earnings and sales projections were lowered on an absolute basis,…
Read more Johnson & Johnson Maintains Dividend After Kenvue SpinoutJohnson & Johnson $35 billion exchange offer for Kenvue that expired last Friday was substantially oversubscribed. The result is that participating J&J holders will be able to convert…
Read more J&J Investors Can Convert Only a Fraction of Shares Into Kenvue StockJohnson and Johnson $40 billion exchange offer for shares in Kenvue is likely to generate strong interest from the healthcare company’s shareholders, resulting in participants being able to…
Read more J&J’s Kenvue Deal Could Be Too Popular. What Happens if It Is.This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/kenvue-jnj-stock-price-exchange-offer-e85c3c90 Updated Aug. 15, 2023…
Read more J&J Investors Must Decide If They Want Kenvue StockU.S. stocks finished mostly lower Thursday, with the Nasdaq and S&P 500 dragged down by disappointing earnings, while the Dow Jones Industrial Average rose for a ninth straight…
Read more Dow posts longest winning streak in nearly 6 years; Nasdaq slumps over 2%IPO investors, much like retail shoppers in recent years’ inflationary environment, are demanding clear discounts and demonstrating sensitivity to price and valuations, according to Renaissance Capital. The provider…
Read more Like choosy shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivityEli Lilly & Co.’s market cap neared Johnson & Johnson’s market cap on Friday, as the stock has benefited from a slew of positive data in trials for…
Read more Eli Lilly nears J&J market capKenvue Inc. shares KVUE, +18.86% were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ, -0.24% spinoff, with consumer brands including Tylenol, Band-Aid and…
Read more Kenvue stock opens 16% above IPO, valuing the company at $47.7 billionA unit of Johnson & Johnson is headed for the biggest initial public offering in more than a year after its shares were priced near the top of…
Read more Johnson & Johnson’s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stocks-raising-dividends-j-j-costco-60f5d6ad April 22, 2023 4:00…
Read more J&J to Lift Dividend for 61st Year. These 6 Firms Are Raising Payouts Too.
